Insight
By Vladimir Murovec, head of life sciences regulatory, Osborne Clarke in Brussels The European Medicines Agency (EMA) and the Heads of Medicines Agencies recently unveiled guiding principles on leveraging large language models (LLMs) within regulatory science and pharmaceutical oversight. These new guidelines, while directed at regulatory authorities, bear implications for pharmaceutical firms and enterprises using or supplying [...]
By Gil Bashe, Health Tech World author and FINN Partners chair of global health and purpose Few regions in the life sciences landscape shine as brightly as the United Kingdom Golden Triangle, which encompasses London, Oxford, and Cambridge. This easily traversable area hosts a wealth of prestigious universities, world-class research institutions, and a well-established but [...]
By Jonathan Bridges, chief innovation officer at Exponential-e. Artificial intelligence (AI) is set to change the field of pathology, transforming how diseases are detected and diagnosed. With its ability to enhance efficiency, accuracy, and the speed of screening, AI can significantly improve the detection of conditions such as breast, bowel, and cervical cancer. As pathology [...]
By Marcus Vass, head of Digital Health, Osborne Clarke The UK Government has introduced The Data (Use and Access) Bill to the House of Lords. The Bill is enabling and aims to drive more effective data use to promote growth across many sectors. This includes some notable proposals for Digital Health and Life Sciences. Common standards to be [...]
By Derrick Measham, Research and Development Director, X-on Health Despite advancements as part of the wider digital front door, across the 6,000+ GP surgeries in England, over two thirds (68 per cent) of patients continue to contact their GP practice via telephone as the first port of call. The transformation of telephony as a key [...]
By Andrey Doronichev, CEO of AI-focused drug discovery infrastructure company Optic. The global drug development landscape is bustling, with over 20,000 biotechs competing for investor attention. Now more than ever, having a decisive edge is crucial to bring the right molecule from target to lead candidate to approved drug. Fast. Generative AI could be the [...]
Rob De Felice, business development director at IEG4, updates on the ongoing challenge of achieving a much-needed integrated healthcare system. When the UK Department of Health and Social Care and the NHS first set out plans for an integrated care model in 2013, they claimed: “For health, care, and support to be ‘integrated’, it must [...]
Sanius Health is excited about the recent developments from the NHS regarding better access for patients to their medical records, alongside the Health Secretary’s vision for patients to take greater control of their health journeys through wearable technology. The company is proud to have been pioneers in this space, particularly in blood cancers, rare diseases, [...]
By Sharon Lamb, Bella North and Michaela Novakova, McDermott Will & Emery
By McDermott Will & Emery
